Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$41,286,262
+$40,589,852 QoQ
Shares Held
3,049,207
+8963.4% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#18
of 626 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capula Management Ltd holds $156,174,841 across 9 Drug Manufacturers - General names. OGN ranks #2 (26.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
300,064 | $108,659,175 | |
| 2 | OGN |
Organon & Co.
This page
|
3,049,207 | $41,286,262 | |
| 3 | PFE |
Pfizer Inc
|
170,245 | $4,099,499 | |
| 4 | ABBV |
AbbVie Inc.
|
3,168 | $797,195 | |
| 5 | LLY |
ELI LILLY & Co
|
596 | $714,860 | |
| 6 | JNJ |
Johnson & Johnson
|
875 | $222,222 | |
| 7 | AZN |
Astrazeneca PLC
|
905 | $171,606 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,147 | $144,911 |
All Filings in OGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,286,262 | 3,049,207 | Shares | Defined | 2026-08-14 | |
| 2024-06-30 | $696,410 | 33,643 | Shares | Defined | 2024-08-05 | |
| 2023-09-30 | $730,161 | 42,060 | Shares | Defined | 2023-11-03 | |
| 2022-12-31 | $495,925 | 17,756 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||